These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7753037)

  • 1. Expression of mRNA for vasoactive intestinal peptide in normal human colon and during inflammation.
    Schulte-Bockholt A; Fink JG; Meier DA; Otterson MF; Telford GL; Hopp K; Koch TR
    Mol Cell Biochem; 1995 Jan; 142(1):1-7. PubMed ID: 7753037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis.
    Renzi D; Mantellini P; Calabrò A; Panerai C; Amorosi A; Paladini I; Salvadori G; Garcea MR; Surrenti C
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):62-70. PubMed ID: 9615269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased colonic peptide histidine-methionine in idiopathic inflammatory bowel diseases.
    Koch TR; Michener SR; Carney JA; Go VL
    Dig Dis Sci; 1988 Apr; 33(4):423-8. PubMed ID: 3349889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colonic vasoactive intestinal polypeptide in ulcerative colitis.
    Surrenti C; Renzi D; Garcea MR; Surrenti E; Salvadori G
    J Physiol Paris; 1993; 87(5):307-11. PubMed ID: 8298608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of colonic vasoactive intestinal peptide and cholinergic activity in rats with chemical colitis.
    Kishimoto S; Kobayashi H; Shimizu S; Haruma K; Tamaru T; Kajiyama G; Miyoshi A
    Dig Dis Sci; 1992 Nov; 37(11):1729-37. PubMed ID: 1425074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseases.
    Koch TR; Carney JA; Go VL
    Dig Dis Sci; 1987 Apr; 32(4):369-76. PubMed ID: 2435473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptidergic nerves in the colon of patients with ulcerative colitis.
    Tomita R; Tanjoh K; Fujisaki S; Fukuzawa M
    Hepatogastroenterology; 2000; 47(32):400-4. PubMed ID: 10791200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colonic vasoactive intestinal polypeptide (VIP) in ulcerative colitis--a radioimmunoassay and immunohistochemical study.
    Todorovic V; Janic B; Koko V; Micev M; Nikolic JA; Ratkovic M; Leposavic G; Jankovic T; Knezevic-Usaj S; Milicevic Z
    Hepatogastroenterology; 1996; 43(9):483-8. PubMed ID: 8799381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
    Daig R; Andus T; Aschenbrenner E; Falk W; Schölmerich J; Gross V
    Gut; 1996 Feb; 38(2):216-22. PubMed ID: 8801200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic chronic constipation is associated with decreased colonic vasoactive intestinal peptide.
    Koch TR; Carney JA; Go L; Go VL
    Gastroenterology; 1988 Feb; 94(2):300-10. PubMed ID: 2446945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial expression of vasoactive intestinal peptide in ulcerative colitis: down-regulation in markedly inflamed colon.
    Jönsson M; Norrgård O; Forsgren S
    Dig Dis Sci; 2012 Feb; 57(2):303-10. PubMed ID: 22143367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased vasoactive intestinal peptide levels and glutathione depletion in acquired megacolon.
    Koch TR; Schulte-Bockholt A; Otterson MF; Telford GL; Stryker SJ; Ballard T; Opara EC
    Dig Dis Sci; 1996 Jul; 41(7):1409-16. PubMed ID: 8689918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease in binding for the neuropeptide VIP in response to marked inflammation of the mucosa in ulcerative colitis.
    Jönsson M; Norrgård O; Hansson M; Forsgren S
    Ann N Y Acad Sci; 2007 Jun; 1107():280-9. PubMed ID: 17804556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total antioxidant capacity of colon in patients with chronic ulcerative colitis.
    Koch TR; Yuan LX; Stryker SJ; Ratliff P; Telford GL; Opara EC
    Dig Dis Sci; 2000 Sep; 45(9):1814-9. PubMed ID: 11052325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pannexin-2 is expressed in the human colon with extensive localization in the enteric nervous system.
    Diezmos EF; Sandow SL; Perera DS; King DW; Bertrand PP; Liu L
    Neurogastroenterol Motil; 2015 May; 27(5):672-83. PubMed ID: 25773474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of MUC2 synthesis in ulcerative colitis.
    Tytgat KM; van der Wal JW; Einerhand AW; Büller HA; Dekker J
    Biochem Biophys Res Commun; 1996 Jul; 224(2):397-405. PubMed ID: 8702401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colonic vasoactive intestinal peptide nerves in inflammatory bowel disease.
    Kubota Y; Petras RE; Ottaway CA; Tubbs RR; Farmer RG; Fiocchi C
    Gastroenterology; 1992 Apr; 102(4 Pt 1):1242-51. PubMed ID: 1551531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin in the idiopathic inflammatory bowel diseases.
    Koch TR; Carney JA; Morris VA; Go VL
    Dis Colon Rectum; 1988 Mar; 31(3):198-203. PubMed ID: 2894935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin releasing hormone in colonic mucosa in patients with ulcerative colitis.
    Kawahito Y; Sano H; Mukai S; Asai K; Kimura S; Yamamura Y; Kato H; Chrousos GP; Wilder RL; Kondo M
    Gut; 1995 Oct; 37(4):544-51. PubMed ID: 7489943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of enteral nervous system in children with drug resistant ulcerative colitis].
    Kamińska B; Landowski P; Gonkowski S; Szlagatys-Sidorkiewicz A; Majewski M; Dobosz M; Ismail H; Korzon M
    Med Wieku Rozwoj; 2007; 11(2 Pt 1):117-22. PubMed ID: 17625279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.